Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

Scope Summary

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-225. Status: posted.

Bid Readiness Checklist

• 1. Portal Registration & Eligibility Mandatory
  Confirm active supplier account on the issuing portal to submit bids to buyer "HHS-NIH11" (US Federal).
  Suggested Evidence: SAM.gov UEI & Grants.gov Authorized Organization Rep (AOR)
• 2. Submission Deadline & Format Mandatory
  Finalize pricing and compliance attachments at least 24 hours ahead of Closes 2027-10-20.
  Suggested Evidence: Signed Cover Form, Mandatory Returnables & Complete File Upload
• 3. Clinical / Research Governance Mandatory
  Confirm regulatory compliance, privacy/confidentiality safeguards, and qualifications of lead specialists.
  Suggested Evidence: Credentials, Governance Policy & Ethics Compliance
• 4. Commercial Pricing Schedule Mandatory
  Structure transparent itemized fixed or T&M rate pricing aligned with notice deliverables (ceiling not disclosed in notice).
  Suggested Evidence: Itemized Pricing Table, Rate Card & Scope Assumptions